| P2093 | author name string | Kamran Mahmood | |
| | John W Christman | |
| | David W Carley | |
| | James J Herdegen | |
| | Kamal Eldeirawi | |
| | Ergün Onal | |
| | Natasha Akhter | |
| P2860 | cites work | Rapid eye movement-related disordered breathing: clinical and polysomnographic features | Q47686338 |
| | Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). | Q48125932 |
| | Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus | Q48490097 |
| | The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome | Q48702588 |
| | Is obstructive sleep apnoea a rapid eye movement-predominant phenomenon? | Q48708908 |
| | The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population | Q48715767 |
| | Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome | Q48783534 |
| | Fluctuations in autonomic nervous activity during sleep displayed by power spectrum analysis of heart rate variability | Q48819209 |
| | Augmented resting sympathetic activity in awake patients with obstructive sleep apnea | Q48867897 |
| | Obesity among adults in the United States--no statistically significant change since 2003-2004 | Q64127774 |
| | Does socioeconomic position moderate the effects of race on cardiovascular disease mortality? | Q81427562 |
| | Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 |
| | C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 |
| | Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment | Q34227249 |
| | Sympathetic-nerve activity during sleep in normal subjects | Q34359210 |
| | Sleep loss results in an elevation of cortisol levels the next evening. | Q34450929 |
| | Ethnicity and obstructive sleep apnoea | Q36267452 |
| | Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation | Q36800564 |
| | Economic costs of diabetes in the U.S. In 2007. | Q37097601 |
| | Association of sleep apnea and type II diabetes: a population-based study | Q37282758 |
| | Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome | Q39655951 |
| | Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output | Q42467904 |
| | Autonomic activity during human sleep as a function of time and sleep stage | Q42672556 |
| | Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes | Q42764571 |
| | The effects of gender and age on REM-related sleep-disordered breathing | Q43632292 |
| | Obstructive sleep apnea is independently associated with insulin resistance. | Q43903080 |
| | Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. | Q43903083 |
| | High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population | Q44301711 |
| | Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. | Q44598192 |
| | Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome | Q44878977 |
| | Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study | Q45048798 |
| | Incidence of diabetes in middle-aged men is related to sleep disturbances | Q45081270 |
| | Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea | Q45287871 |
| | Snoring as a risk factor for type II diabetes mellitus: a prospective study | Q45305411 |
| | Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. | Q46027770 |
| | Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. | Q46184387 |
| | Sleep duration as a risk factor for the development of type 2 diabetes | Q46966750 |
| | Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea | Q47234433 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| | multiethnicity | Q111242702 |
| | obstructive sleep apnea | Q16606552 |
| P304 | page(s) | 215-221 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | The Journal of Clinical Sleep Medicine | Q15766748 |
| P1476 | title | Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample | |
| P478 | volume | 5 | |